AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
UBS
ACCE-researched

UBS Group AG Registered Ordinary Shares (UBS) fair value

Financial Services · Banks - Diversified · NYSE · United States
$46.37-1.07%
Market cap $142.0BNext earnings 2026-10-28Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 26% above our fair value
Price
$46.37
Model fair valueConfidence: good
$36.70
Model range
$29.39 to $40.48
Fair value $36.70
Price $46.37
3 models fit UBS Group AG Registered Ordinary Shares and they partly agree: 2 of 3 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Premium(i)Bronze55
Valued as a bank: Residual income, P/E comparison, Dividend discount, and Graham number.
ACCE opinionUBS Group AG Registered Ordinary Shares (UBS)
Fair value (3 models)
$36.70
ACCE price target
$52.00
Rating
Overvalued
Horizon
12 months
Fair value published on 11 Oct 2026, 00:00 CEST; previously $27.50 since 5 Oct 2026, 00:00 CEST.
ACCE price target published on 17 Sept 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 19:04 CEST.
Price used: $46.37 at the close on 23 Oct 2026, 22:00 CEST.
Models: Dividend discount, Graham number, P/E comparison, and Residual income.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
26.4% above
-20.9% to fair value
ACCE score
68
out of 100
Analysts
33% buy
3 covering
P/E
15.8x
forward 11.6x
1-year return
+21.3%
Dividend yield
2.35%

UBS Group AG Registered Ordinary Shares in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

UBS operates a global investment bank, wealth management platform serving ultra-high-net-worth clients, and Swiss retail banking franchise. The wealth management division manages $5 trillion in invested assets and generates recurring fee income with minimal capital requirements, creating a structural moat against cyclical downturns. Net new money inflows into wealth management have accelerated to $71 billion in the first half of 2024, driven by geopolitical uncertainty pushing capital toward established Swiss institutions. The forward PE of 11.6x trades at a discount to global diversified banks despite ROE of 10.7% and operating margins of 31%, reflecting market skepticism about post-acquisition integration and regulatory capital requirements. At current valuations, the wealth management franchise alone justifies a meaningful portion of the enterprise value, leaving investment banking and Swiss retail as optionality.

AI-assisted·How I use AIWritten Oct 12, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • moderate
    Leverage elevated for banking sector
    Debt/Equity of 3.95 is structurally high for banks but warrants monitoring given recent sector stress and regulatory scrutiny on capital ratios.
  • moderate
    Sequential revenue decline
    QoQ revenue down 0.4% despite strong YoY growth of 14.6%, suggesting recent momentum loss or seasonal weakness in latest quarter.
  • moderate
    ACCE score erosion
    Score fell 3 points over 90 days (73 to 70), with Quality sub-score at 64, indicating deteriorating fundamentals relative to model expectations.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • UBS generates strong free cash flow of $15.5B with a 10.5% yield, enabling shareholder returns.
  • Revenue has grown 18.2% annually over five years, demonstrating consistent business momentum.
  • At 11.6x forward P/E, UBS trades below the 11.9x sector median despite a 17.9% net margin.
Why it could disappoint
  • Consensus fair value is $36.57, implying 24.0% downside from the current $48.13 share price.
  • Return on invested capital of 1.4% is far below the cost of capital for a bank with 3.95x leverage.
  • Only 33% of analysts rate the stock Buy or Strong Buy, and latest earnings missed expectations by 3.3%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Oct 28, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where UBS's valuation models land
Price
$46.37
Model fair value
$36.70
Model range
$29.39 to $40.48
Fair value $36.70
Price $46.37
The price is above the whole model range.
Model
Fair value
Upside
Dividend discount
Graham number
P/E comparison
Residual income
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish33% buy · 3 covering analysts
● Strong buy 1● Buy 0● Hold 2● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-2.7%
1 month
-2.9%
3 months
-10.4%
6 months
+12.0%
YTD
+0.1%
1 year
+21.3%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
19 Oct 2026, 19:04 CESTRatingOvervaluedfirst publication$47.68
11 Oct 2026, 00:00 CESTFair value$36.57$27.50$48.13
5 Oct 2026, 00:00 CESTFair value$27.50$27.88$47.71
1 Oct 2026, 00:00 CESTFair value$27.88$28.20$48.78
24 Sept 2026, 00:00 CESTFair value$28.20$28.72$49.19
17 Sept 2026, 00:00 CESTACCE price target$52.00first publication$50.42
17 Sept 2026, 00:00 CESTFair value$28.72$29.37$51.49
31 Aug 2026, 00:00 CESTFair value$29.37$36.93$54.36
19 Aug 2026, 00:00 CESTFair value$36.93$34.55$52.91
31 Jul 2026, 00:00 CESTFair value$34.55$34.19$52.37

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full UBS page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth68Value70Quality64Momentum68Total68
Valuation
Trailing P/E
15.8x
Forward P/E
11.6x
PEG
0.77
P/B
1.69x
EV / Revenue
7.8x
Book value/sh
$29.12
Enterprise value
$166.1B
Profitability
ROE
10.7%
FCF yield
10.89%
ROIC
1.4%
Health and risk
Debt / equity
3.95
Dividend yield
2.35%
Beta
0.85

Price

+22.0% · 1Y

Ask anything about UBS

Answered from UBS Group AG Registered Ordinary Shares fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 33% of peers
low 11.4x15.8xhigh 19.3x
ROEbetter than 67% of peers
low 9%11%high 19%
Div yieldbetter than 0% of peers
low 2.4%2.4%high 4.3%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
UBS UBS Group AG Registered Ordinary Shares$46.37$3726% above15.8x10.7%6468
UBSG.SW UBS GroupCHF 38.32CHF 2646% above16.4x10.7%6470
BBVA Banco Bilbao Vizcaya Argentaria S.A. Common Stock$24.88$244% above11.4x18.9%8679
BBVA.MC Banco Bilbao Vizcaya Argentaria€22.23€1821% above11.4x18.9%8181
8316.T Sumitomo Mitsui Financial Group¥3114.00¥208549% above14.5x8.6%6164
SMFG Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan)$23.80$1739% above13.9x8.6%6772
BMO.TO Bank of MontrealC$236.87C$16246% above19.3x10.6%6763

Sector report card

Where UBS ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Oct 13, 2026
    Major Shareholder Announcement
  • Business Wire•Oct 9, 2026
    Azelis: Transparency Notification from UBS Group AG
  • Business Wire•Oct 8, 2026
    Azelis: Transparency Notification From UBS Group AG
14 more press releases · full archive on Investor+.INVESTOR
40 filings
August 2026
Aug 14
6-KForeign current reportPeriod 2026-06-30
View on SEC →
July 2026
Jul 30
6-KForeign current reportPeriod 2026-06-30
View on SEC →
Jul 29
6-KForeign current reportPeriod 2026-07-29
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR